Bioavailability, Metabolism, and Bioactivity of Food Ellagic Acid and Related Polyphenols

Recent Advances in Polyphenol Research

Volumn 1, Issue , 2008, Pages 263-277

  Tomás Barberán, Francisco A ^a   García Conesa, Maria Teresa ^a   Larrosa, Mar ^a   Cerdá, Begoña ^a   González Barrio, Rocio ^a   Bermúdez Soto, Maria José ^a   González Sarrías, Antonio ^a   Espín, Juan Carlos ^a  

^a RESEARCH GROUP ON QUALITY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

POLYPHENOLS;

BIOCHEMISTRY;

EID: 77954084714     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444302400.ch11     Document Type: Chapter

References (31)

1. Arts, I.C.W. & Hollman, P.C.H. (2005). Polyphenols and disease risk in epidemiologic studies. American Journal of Clinical Nutrition, 81, 317S-325S.
2. Aviram, M., Kent, U.M. & Hollenbergh, P.F. (1999). Microsomal cytochrome P450 catalyzes oxidation of low density lipoprotein. Atherosclerosis, 143, 253-260.
3. Aviram, M., Dornfeld, L., Rosenblat, M. et al. (2000). Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. American Journal of Clinical Nutrition, 71, 1062-1076.
4. Aviram, M. & Dornfeld, L. (2001). Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduced systolic pressure. Atherosclerosis, 158, 195-198.
5. Aviram, M., Dornfeld, L., Kaplan, M. et al. (2002). Pomegranate juice flavonoids inhibit low density lipoprotein oxidation and cardiovascular diseases: Studies in atherosclerotic mice and humans. Drugs under Experimental and Clinical Research, 28, 49-62.
6. Aviram, M., Rosenblat, M., Gaitini, D. et al. (2004). Pomegranate juice consumption for three years by patients with carotid arterial stenosis reduces common carotid-media thickness, blood pressure and LDL oxidation. Clinical Nutrition, 23, 423-433.
7. Blomhoff, R., Carlsen, M.H., Andersen, L.F. & Jacobs, D.R. (2006). Health benefits of nuts: potential role of antioxidants. British Journal of Nutrition, 96, S52-S60.
8. Cantos, E., Espín, J.C., López-Bote, C., De la Hoz, L., Ordóñez, J.A. & Tomás-Barberán, F.A. (2003). Phenolic compounds and fatty acids from acorns (Quercus spp.), the main dietary constituent of free-range Iberian pigs. Journal of Agricultural and Food Chemistry, 51, 6248-6255.
9. Cerdá, B., Llorach, R., Cerón, J.J., Espín, J.C. & Tomás-Barberán, F.A. (2003a). Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice. European Journal of Nutrition, 42, 18-28.
10. Cerdá, B., Cerón, J.J., Espín, J.C. & Tomás-Barberán, F.A. (2003b). The repeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxic. Journal of Agricultural and Food Chemistry, 51, 3493-3501.
11. Cerdá, B., Espín, J.C., Parra, A., Martínez, P. & Tomás-Barberán, F.A. (2004). The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolized into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans. European Journal of Nutrition, 43, 205-220.
12. Cerdá, B., Tomás-Barberán, F.A. & Espín, J.C. (2005). Metabolism of antioxidant and chemopre- ventive ellagitannins from strawberries, raspberries, walnuts and oak-aged wine in humans: Identification of biomarkers and individual variability. Journal of Agricultural and Food Chemistry, 53, 227-235.
13. Cerdá, B., Soto, M.C., Albaladejo, M.D. et al. (2006). Pomegranate juice supplementation in COPD: a 5-week randomised, double blind, placebo-controlled trial. European Journal of Clinical Nutrition, 60, 245-253.
14. Espín, J.C., González-Barrio, R., Cerdá, B., López-Bote, C., Rey, A.I., Tomas-Barberan, F.A. (2007). Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagi- tannins in humans', Journal of Agricultural and Food Chemistry, 55, 10476-10485.
15. Ferreres, F., Andrade, P., Gil, M.I. & Tomás-Barberán, F.A. (1996). Floral nectar phenolics as biochemical markers for the botanical origin of heather honey. Zeitschrift für LebensmittelUntersuchung und -Forschung, 202, 40-44.
16. Fuhrman, B. & Aviram, M. (2006). Protection against cardiovascular diseases. In: Pomegranates. Ancient Roots to Moderm Medicine (eds N.P. Seeram, R.N. Schulman & D. Heber), pp. 63-89. CRC Taylor & Francis, Boca Raton, USA.
17. Fukuda, T., Ito, H. & Yoshida, T. (2003). Antioxidative polyphenols from walnuts (Juglans regia L.). Phytochemistry, 63, 795-801.
18. Gil, M.I., Tomás-Barberán, F.A., Hess-Pierce, B., Holcroft, D.M. & Kader, A.A. (2000). Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. Journal of Agricultural and Food Chemistry, 48, 4581-4589.
19. Glabasnia, A. & Hofmann, T. (2006). Sensory-directed identification of taste-active ellagitannins in American (Quercus alba L.) and European oak wood (Quercus robur L.) and quantitative analysis in bourbon whiskey and oak-matured red wines. Journal of Agricultural and Food Chemistry, 54, 3380-3390.
20. Hannum, S.M. (2004). Potential impact of strawberries on human health: a review of the science. Critical Reviews in Food Science and Nutrition, 44, 1-17.
21. Hidaka, M., Okumura, M., Fujita, K. et al. (2005). Effects of pomegranate juice on human cytochrome P450 3A (CYP3A) and carbamazepine pharmacokinetics in rats. Drug Metabolism and Disposition, 33, 644-648.
22. Larrosa, M., Tomás-Barberán, F.A. & Espín, J.C. (2006a). The hydrolysable tannin punicalagin releases ellagic acid which induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway. Journal of Nutritional Biochemistry, 17, 611-625.
23. Larrosa, M., González-Sarrías, A., García-Conesa, M.T., Tomás-Barberán, F.A. & Espín, J.C. (2006b). Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities. Journal of Agricultural and Food Chemistry, 54, 1611-1620.
24. Mertens-Talcott, S.U., Jilma-Stohlawetz, P., Rios, J., Hingorani, L. & Derendorf, H. (2006). Absorption, metabolism, and antioxidant effects of pomegranate (Punica granatum L.) polyphenols after ingestion of a standardized extract in healthy human volunteers. Journal of Agricultural and Food Chemistry, 54, 8956-8961.
25. Seeram, N.P., Lee, R. & Heber, D. (2004). Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice. Clinica Chimica Acta, 348, 63-68.
26. Seeram, N.P., Henning, S.M., Zhang, Y., Suchard, M., Li, Z. & Heber, D. (2006). Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours. The Journal of Nutrition, 136, 2481-2485.
27. Shoji, T., Masumoto, S., Moriichi, N. et al. (2006). Apple procyanidin oligomers absorption in rats after oral administration: Analysis of procyanidins in plasma using the Porter method and high-performance liquid chromatography/tanden mass spectrometry. Journal of Agricultural and Food Chemistry, 54, 884-892.
28. Sorokin, A.V., Duncan, B., Panetta, R. & Thompson, P.D. (2006). Rhabdomyolysis associated with pomegranate juice consumption. American Journal of Cardiology, 98, 705-706.
29. Stoner, G.D., Sardo, C., Apseloff, G. et al. (2005). Pharmacokinetics of anthocyanins and ellagic acid in healthy volunteers fed freeze-dried black raspberries daily for 7 days. Journal of Clinical Pharmacology, 45, 1153-1164.
30. Villarreal-Lozoya, J.E., Lombardini, L. & Cisneros-Zevallos, L. (2007). Phytochemical constituents and antioxidant capacity of different pecan (Carya illinoinensis [Wangenh.] K. Koch) cultivars. Food Chemistry, 102, 1241-1249.
31. Zafrilla, P., Ferreres, F. & Tomás-Barberán, F.A. (2001). Effect of processing and storage on the antioxidant ellagic acid derivatives and flavonoids of red raspberry (Rubus idaeus) jams. Journal of Agricultural and Food Chemistry, 49, 3651-3655.